SAN FRANCISCOMost companies developing cancer drugs want to kill outofcontrol tumor cells Agios Pharmaceuticals Inc wants to repair them The Cambridge Massbased drug companys lead drug called AG targets a genetic mutation that prevents certain white blood cells from maturing into normalfunctioning infectionfighting cells The anomaly leads to anemia and development of acute myeloid leukemia and other similar blood cancers 